Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...

Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise Research Campus in Allston that could employ hundreds. The Roche ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Gulyamov was diagnosed with pre-eclampsia, a potentially dangerous complication that manifests as high blood pressure, protein in the woman’s urine, and often swelling that is indistinct from ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Afore Capital, a firm that claims to be the largest dedicated pre-seed investor, was founded on the idea that the first check into a new startup should be larger than what most accelerators and ...

The Air Force will have to continue maintaining Minuteman III nuclear missiles longer than expected, with the LGM-35A Sentinel successor requiring a major restructuring that will delay its fielding.

In the new study, researchers used data from 8,843 women diagnosed with preeclampsia at a median gestational age of 36 weeks between 2003 and 2016. Data included PIERS-ML and fullPIERS assessments ...

With just a few weeks to go before the full announcement, many are revving their engines for full Nintendo Switch 2 pre-orders to open next month. That April 2 Direct date is approaching fast, and ...

As a former claims handler and fraud investigator, Jason Metz has worked on a multitude of complex and multifaceted claims. The insurance industry can be seemingly opaque, and Jason enjoys ...

Michelle is a lead editor at Forbes Advisor. She has been a journalist for over 35 years, writing about insurance for consumers for the last decade. Prior to covering insurance, Michelle was a ...